AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $761,864 | +55.3% | 1,691,151 | 0.0% | 0.37% | +58.1% |
Q1 2023 | $490,434 | -35.6% | 1,691,151 | 0.0% | 0.24% | -53.0% |
Q4 2022 | $761,018 | -14.5% | 1,691,151 | 0.0% | 0.50% | -15.1% |
Q3 2022 | $890,000 | +4.2% | 1,691,151 | 0.0% | 0.59% | -3.0% |
Q2 2022 | $854,000 | -78.0% | 1,691,151 | 0.0% | 0.61% | -71.0% |
Q1 2022 | $3,890,000 | -51.6% | 1,691,151 | 0.0% | 2.10% | -25.9% |
Q4 2021 | $8,033,000 | -40.3% | 1,691,151 | 0.0% | 2.83% | +5.7% |
Q3 2021 | $13,445,000 | +14.2% | 1,691,151 | 0.0% | 2.68% | +42.3% |
Q2 2021 | $11,770,000 | -12.1% | 1,691,151 | 0.0% | 1.88% | -21.9% |
Q1 2021 | $13,394,000 | +0.6% | 1,691,151 | 0.0% | 2.41% | +5.5% |
Q4 2020 | $13,309,000 | +11.0% | 1,691,151 | 0.0% | 2.29% | -40.3% |
Q3 2020 | $11,990,000 | -23.4% | 1,691,151 | 0.0% | 3.83% | -35.8% |
Q2 2020 | $15,643,000 | +160.0% | 1,691,151 | +31.0% | 5.97% | +127.8% |
Q1 2020 | $6,017,000 | -39.0% | 1,291,151 | 0.0% | 2.62% | -30.6% |
Q4 2019 | $9,864,000 | -0.7% | 1,291,151 | 0.0% | 3.78% | -27.0% |
Q3 2019 | $9,929,000 | +12.3% | 1,291,151 | 0.0% | 5.18% | +37.0% |
Q2 2019 | $8,844,000 | -10.0% | 1,291,151 | +5.8% | 3.78% | -49.6% |
Q1 2019 | $9,828,000 | +51.1% | 1,220,911 | +40.6% | 7.49% | +9.2% |
Q4 2018 | $6,506,000 | – | 868,621 | – | 6.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |